FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Caldwell

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Anatomy

Concepts & Ideas

Time Factors

Co-author Network

Publications

TOP 3
Hua Liu; Zhimin Xu; Wenbo Zhang; Ruth B Caldwell; Robert W Caldwell; Steven E Brooks
Hyperoxia causes regression of vitreous neovascularization by downregulating VEGF/VEGFR2 pathway.
Rudolf Lucas; Michael A Matthay; Timothy J Mitchell; Jean-François Pittet; Maritza J Romero; Supriya Sridhar; Nagavedi S Umapathy; Alexander D Verin; Guang Yang; Evgeny A Zemskov; Irina B Alieva; Ruth B Caldwell; Robert W Caldwell; John D Catravas; Stephen D Cederbaum; Bernhard Fischer; David J Fulton; Boris A Gorshkov; Hamid Hossain; Agnieszka Jezierska-Drutel; Martin Leustik; Trinad Chakraborty
Protein kinase C-α and arginase I mediate pneumolysin-induced pulmonary endothelial hyperpermeability.
Maritza J Romero; M Irfan Ali; Ruth B Caldwell; David W Stepp; Daniel H Platt; Stephen D Cederbaum; Jennifer A Iddings; Robert W Caldwell
Diabetes-induced vascular dysfunction involves arginase I.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Caldwell (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Hua Liu; Zhimin Xu; Wenbo Zhang; Ruth B Caldwell; Robert W Caldwell; Steven E Brooks
Hyperoxia causes regression of vitreous neovascularization by downregulating VEGF/VEGFR2 pathway.
Investigative ophthalmology & visual science 2013;54(2):918-31.
2012: Rudolf Lucas; Michael A Matthay; Timothy J Mitchell; Jean-François Pittet; Maritza J Romero; Supriya Sridhar; Nagavedi S Umapathy; Alexander D Verin; Guang Yang; Evgeny A Zemskov; Irina B Alieva; Ruth B Caldwell; Robert W Caldwell; John D Catravas; Stephen D Cederbaum; Bernhard Fischer; David J Fulton; Boris A Gorshkov; Hamid Hossain; Agnieszka Jezierska-Drutel; Martin Leustik; Trinad Chakraborty
Protein kinase C-α and arginase I mediate pneumolysin-induced pulmonary endothelial hyperpermeability.
American journal of respiratory cell and molecular biology 2012;47(4):445-53.
2012: Maritza J Romero; M Irfan Ali; Ruth B Caldwell; David W Stepp; Daniel H Platt; Stephen D Cederbaum; Jennifer A Iddings; Robert W Caldwell
Diabetes-induced vascular dysfunction involves arginase I.
American journal of physiology. Heart and circulatory physiology 2012;302(1):H159-66.
2012: S Chandra; A M Alkilany; Ruth B Caldwell; A Shatanawi; M J Romero; Robert W Caldwell
Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway.
British journal of pharmacology 2012;165(2):506-19.
2011: Wenbo Zhang; Ruth B Caldwell; Robert W Caldwell; Dennis M Marcus; Subhadra P Narayanan; Zhimin Xu; Lauren Yancey; Harumasa Yokota; Akitoshi Yoshida; Steven E Brooks
Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model.
Investigative ophthalmology & visual science 2011;52(9):6384-95.
2011: Wenbo Zhang; Hua Liu; Modesto Rojas; Robert W Caldwell; Ruth B Caldwell
Anti-inflammatory therapy for diabetic retinopathy.
Immunotherapy 2011;3(5):609-28.
2011: Alia Shatanawi; Maritza J Romero; Jennifer A Iddings; Surabhi Chandra; Nagavedi S Umapathy; Alexander Dmitriyevich Verin; Ruth B Caldwell; Robert W Caldwell
Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway.
American journal of physiology. Cell physiology 2011;300(5):C1181-92.
2011: Wenbo Zhang; Mohamed Al-Shabrawey; Robert W Caldwell; Hua Liu; Ruth B Caldwell
Inflammation and diabetic retinal microvascular complications.
Journal of cardiovascular disease research 2011;2(2):96-103.
2011: Haroldo A Toque; Rita C Tostes; R Clinton Webb; Zhimin Xu; Lin Yao; Ruth B Caldwell; Robert W Caldwell
Arginase II deletion increases corpora cavernosa relaxation in diabetic mice.
The journal of sexual medicine 2011;8(3):722-33.
2011: Harumasa Yokota; Akitoshi Yoshida; Wenbo Zhang; Steven E Brooks; Robert W Caldwell; Tahira Lemtalsi; Hua Liu; Taiji Nagaoka; Subhadra P Narayanan; Modesto Rojas; Zhimin Xu; Ruth B Caldwell
Neuroprotection from retinal ischemia/reperfusion injury by NOX2 NADPH oxidase deletion.
Investigative ophthalmology & visual science 2011;52(11):8123-31.
2011: Subhadra P Narayanan; Alan B Saul; Amber Still; Jutamas Suwanpradid; Zhimin Xu; Robert W Caldwell; Ruth B Caldwell
Arginase 2 deletion reduces neuro-glial injury and improves retinal function in a model of retinopathy of prematurity.
PloS one 2011;6(7):e22460.
2010: Haroldo A Toque; Maritza J Romero; Rita C A Tostes; Alia Shatanawi; Surabhi Chandra; Zidonia N Carneiro; Edward Inscho; R Clinton Webb; Ruth B Caldwell; Robert W Caldwell
p38 Mitogen-activated protein kinase (MAPK) increases arginase activity and contributes to endothelial dysfunction in corpora cavernosa from angiotensin-II-treated mice.
The journal of sexual medicine 2010;7(12):3857-67.
2010: Lin Yao; Maritza J Romero; Haroldo A Toque; Guang Yang; Ruth B Caldwell; Robert W Caldwell
The role of RhoA/Rho kinase pathway in endothelial dysfunction.
Journal of cardiovascular disease research 2010;1(4):165-70.
2010: R Datar; Wayne H Kaesemeyer; S Chandra; David J Fulton; Robert W Caldwell
Acute activation of eNOS by statins involves scavenger receptor-B1, G protein subunit Gi, phospholipase C and calcium influx.
British journal of pharmacology 2010;160(7):1765-72.
2010: Guang Yang; Rudolf Lucas; Ruth B Caldwell; Lin Yao; Maritza J Romero; Robert W Caldwell
Novel mechanisms of endothelial dysfunction in diabetes.
Journal of cardiovascular disease research 2010;1(2):59-63.
2010: Modesto Rojas; Wenbo Zhang; Dexter L Lee; Maritza J Romero; Doan T Nguyen; Mohamed Al-Shabrawey; Nai-Tse Tsai; Gregory I Liou; Michael W Brands; Robert W Caldwell; Ruth B Caldwell
Role of IL-6 in angiotensin II-induced retinal vascular inflammation.
Investigative ophthalmology & visual science 2010;51(3):1709-18.
2010: Ruth B Caldwell; Wenbo Zhang; Maritza J Romero; Robert W Caldwell
Vascular dysfunction in retinopathy-an emerging role for arginase.
Brain research bulletin 2010;81(2-3):303-9.
2010: Azza B El-Remessy; Huda E Tawfik; Suraporn Matragoon; Bindu Pillai; Ruth B Caldwell; Robert W Caldwell
Peroxynitrite mediates diabetes-induced endothelial dysfunction: possible role of Rho kinase activation.
Experimental diabetes research 2010;2010():247861.
2009: Manuela Bartoli; Mohamed Al-Shabrawey; Mohamed Labazi; M Ali Behzadian; Mohamed Istanboli; Azza B El-Remessy; Robert W Caldwell; Dennis M Marcus; Ruth B Caldwell
HMG-CoA reductase inhibitors (statin) prevents retinal neovascularization in a model of oxygen-induced retinopathy.
Investigative ophthalmology & visual science 2009;50(10):4934-40.
2009: Wenbo Zhang; Babak Baban; Modesto Rojas; Sohrab Tofigh; Suvika K Virmani; Chintan Patel; M Ali Behzadian; Maritza J Romero; Robert W Caldwell; Ruth B Caldwell
Arginase activity mediates retinal inflammation in endotoxin-induced uveitis.
The American journal of pathology 2009;175(2):891-902.
2009: Sherman M Chamberlain; Joshua D Hall; Jigneshkumar Patel; Jeffrey R Lee; Dennis M Marcus; Subbaramiah Sridhar; Maritza J Romero; Mohamed Labazi; Robert W Caldwell; Manuela Bartoli
Protective effects of the carotenoid zeaxanthin in experimental nonalcoholic steatohepatitis.
Digestive diseases and sciences 2009;54(7):1460-4.
2009: Wenbo Zhang; Modesto Rojas; Brenda J Lilly; Nai-Tse Tsai; Tahira Lemtalsi; Gregory I Liou; Robert W Caldwell; Ruth B Caldwell
NAD(P)H oxidase-dependent regulation of CCL2 production during retinal inflammation.
Investigative ophthalmology & visual science 2009;50(6):3033-40.
2008: J S Penn; A Madan; Ruth B Caldwell; Manuela Bartoli; Robert W Caldwell; M Elizabeth Hartnett
Vascular endothelial growth factor in eye disease.
Progress in retinal and eye research 2008;27(4):331-71.
2008: Mohamed Al-Shabrawey; Manuela Bartoli; Azza B El-Remessy; Guochuan Ma; Suraporn Matragoon; Tahira Lemtalsi; Robert W Caldwell; Ruth B Caldwell
Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy.
Investigative ophthalmology & visual science 2008;49(7):3231-8.
2008: Qilin Yu; Tiffany Nguyen; Mourad Ogbi; Robert W Caldwell; John A Johnson
Differential loss of cytochrome-c oxidase subunits in ischemia-reperfusion injury: exacerbation of COI subunit loss by PKC-epsilon inhibition.
American journal of physiology. Heart and circulatory physiology 2008;294(6):H2637-45.
2008: Maritza J Romero; Daniel H Platt; Huda E Tawfik; Mohamed Labazi; Azza B El-Remessy; Manuela Bartoli; Ruth B Caldwell; Robert W Caldwell
Diabetes-induced coronary vascular dysfunction involves increased arginase activity.
Circulation research 2008;102(1):95-102.
2007: Dehuang Guo; Tiffany Nguyen; Mourad Ogbi; Huda E Tawfik; Guochun Ma; Qilin Yu; Robert W Caldwell; John A Johnson
Protein kinase C-epsilon coimmunoprecipitates with cytochrome oxidase subunit IV and is associated with improved cytochrome-c oxidase activity and cardioprotection.
American journal of physiology. Heart and circulatory physiology 2007;293(4):H2219-30.
2007: Liming Jin; Ruth B Caldwell; T Li-Masters; Robert W Caldwell
Homocysteine induces endothelial dysfunction via inhibition of arginine transport.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2007;58(2):191-206.
2006: Huda E Tawfik; Azza B El-Remessy; Suraporn Matragoon; Guochuan Ma; Ruth B Caldwell; Robert W Caldwell
Simvastatin improves diabetes-induced coronary endothelial dysfunction.
The Journal of pharmacology and experimental therapeutics 2006;319(1):386-95.
2006: Maritza J Romero; Daniel H Platt; Ruth B Caldwell; Robert W Caldwell
Therapeutic use of citrulline in cardiovascular disease.
Cardiovascular drug reviews 2006;24(3-4):275-90.
2006: Guochuan Ma; Mohamed Al-Shabrawey; John A Johnson; Rahul Datar; Huda E Tawfik; Dehuang Guo; Ruth B Caldwell; Robert W Caldwell
Protection against myocardial ischemia/reperfusion injury by short-term diabetes: enhancement of VEGF formation, capillary density, and activation of cell survival signaling.
Naunyn-Schmiedeberg's archives of pharmacology 2006;373(6):415-27.
2006: Amy Kissiah Banes-Berceli; Seán Shaw; Guochuan Ma; Michael W Brands; Douglas C. Eaton; David M Stern; David J Fulton; Robert W Caldwell; Mario B Marrero
Effect of simvastatin on high glucose- and angiotensin II-induced activation of the JAK/STAT pathway in mesangial cells.
American journal of physiology. Renal physiology 2006;291(1):F116-21.
2005: Amany Tawfik; Liming Jin; Amy Kissiah Banes-Berceli; Ruth B Caldwell; Safia Ogbi; Amanda Shirley; Dwayne Barber; John D Catravas; David M Stern; David J Fulton; Robert W Caldwell; Mario B Marrero
Hyperglycemia and reactive oxygen species mediate apoptosis in aortic endothelial cells through Janus kinase 2.
Vascular pharmacology 2005;43(5):320-6.
2005: Mohamed Al-Shabrawey; Manuela Bartoli; Azza B El-Remessy; Daniel H Platt; Suraporn Matragoon; M Ali Behzadian; Robert W Caldwell; Ruth B Caldwell
Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy.
The American journal of pathology 2005;167(2):599-607.
2005: Ruth B Caldwell; Manuela Bartoli; M Ali Behzadian; Azza B El-Remessy; Mohamed Al-Shabrawey; Daniel H Platt; Gregory I Liou; Robert W Caldwell
Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress.
Current drug targets 2005;6(4):511-24.
2005: Adviye Ergul; Jeanette Schultz Johansen; Catherine Strømhaug; Alex K Harris; Jimmie Hutchinson; Amany Tawfik; Ali Rahimi; Edward Rhim; Bryan Wells; Robert W Caldwell; Mark Anstadt
Vascular dysfunction of venous bypass conduits is mediated by reactive oxygen species in diabetes: role of endothelin-1.
The Journal of pharmacology and experimental therapeutics 2005;313(1):70-7.
2004: Gamal Abou-Mohamed; John A Johnson; Liming Jin; Azza B El-Remessy; K Do; Wayne H Kaesemeyer; Ruth B Caldwell; Robert W Caldwell
Roles of superoxide, peroxynitrite, and protein kinase C in the development of tolerance to nitroglycerin.
The Journal of pharmacology and experimental therapeutics 2004;308(1):289-99.
2003: Ruth B Caldwell; Manuela Bartoli; M Ali Behzadian; Azza B El-Remessy; Mohamed Al-Shabrawey; Daniel H Platt; Robert W Caldwell
Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.
Diabetes/metabolism research and reviews 2003;19(6):442-55.
2003: Azza B El-Remessy; Ibrahim E Khalil; Suraporn Matragoon; Gamal Abou-Mohamed; Nai-Jer Tsai; Penny Roon; Ruth B Caldwell; Robert W Caldwell; Keith Green; Gregory I Liou
Neuroprotective effect of (-)Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite.
The American journal of pathology 2003;163(5):1997-2008.
2003: Gamal Abou-Mohamed; Ahmed A Elmarakby; Gerald O Carrier; John D Catravas; Robert W Caldwell; Richard E White
Estradiol relaxes rat aorta via endothelium-dependent and -independent mechanisms.
Pharmacology 2003;69(1):20-6.
2003: Azza B El-Remessy; Gamal Abou-Mohamed; Robert W Caldwell; Ruth B Caldwell
High glucose-induced tyrosine nitration in endothelial cells: role of eNOS uncoupling and aldose reductase activation.
Investigative ophthalmology & visual science 2003;44(7):3135-43.
2003: Azza B El-Remessy; M Ali Behzadian; Gamal Abou-Mohamed; Telina Franklin; Robert W Caldwell; Ruth B Caldwell
Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor.
The American journal of pathology 2003;162(6):1995-2004.
2002: John O Parker; John D Parker; Robert W Caldwell; Bernice Farrell; Wayne H Kaesemeyer
The effect of supplemental L-arginine on tolerance development during continuous transdermal nitroglycerin therapy.
Journal of the American College of Cardiology 2002;39(7):1199-203.
2001: Liming Jin; Gamal Abou-Mohamed; Ruth B Caldwell; Robert W Caldwell
Endothelial cell dysfunction in a model of oxidative stress.
Medical science monitor : international medical journal of experimental and clinical research 2001;7(4):585-91.
2000: Wayne H Kaesemeyer; A A Ogonowski; Liming Jin; Ruth B Caldwell; Robert W Caldwell
Endothelial nitric oxide synthase is a site of superoxide synthesis in endothelial cells treated with glyceryl trinitrate.
British journal of pharmacology 2000;131(5):1019-23.
2000: Wayne H Kaesemeyer; Robert W Caldwell
Atherosclerosis and nitric oxide production.
Circulation 2000;102(11):E90.
2000: Mark S F Clarke; CR Vanderburg; Marcas M Bamman; Robert W Caldwell; Daniel L Feeback
In situ localization of cholesterol in skeletal muscle by use of a monoclonal antibody.
Journal of applied physiology (Bethesda, Md. : 1985) 2000;89(2):731-41.
2000: Gamal Abou-Mohamed; J Huang; C D Oldham; Traci A Taylor; Liming Jin; Ruth B Caldwell; Sheldon W May; Robert W Caldwell
Vascular and endothelial actions of inhibitors of substance P amidation.
Journal of cardiovascular pharmacology 2000;35(6):871-80.
2000: Gamal Abou-Mohamed; Wayne H Kaesemeyer; Ruth B Caldwell; Robert W Caldwell
Role of L-arginine in the vascular actions and development of tolerance to nitroglycerin.
British journal of pharmacology 2000;130(2):211-8.
2000: A A Ogonowski; Wayne H Kaesemeyer; Liming Jin; Vadivel Ganapathy; Fred H Leibach; Robert W Caldwell
Effects of NO donors and synthase agonists on endothelial cell uptake of L-Arg and superoxide production.
American journal of physiology. Cell physiology 2000;278(1):C136-43.
1999: Wayne H Kaesemeyer; Ruth B Caldwell; J Huang; Robert W Caldwell
Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions.
Journal of the American College of Cardiology 1999;33(1):234-41.
1998: HK Desai; B P Hart; Robert W Caldwell; J H Jianzhong-Huang; SW Pelletier
Certain norditerpenoid alkaloids and their cardiovascular action.
Journal of natural products 1998;61(6):743-8.
1998: Gamal Abou-Mohamed; Andreas Papapetropoulos; John D Catravas; Robert W Caldwell
Zn2+ inhibits nitric oxide formation in response to lipopolysaccharides: implication in its anti-inflammatory activity.
European journal of pharmacology 1998;341(2-3):265-72.
1997: C D Oldham; C Li; J Feng; R O Scott; W Z Wang; AB Moore; P R Girard; J Huang; Ruth B Caldwell; Robert W Caldwell; Sheldon W May
Amidative peptide processing and vascular function.
The American journal of physiology 1997;273(6 Pt 1):C1908-14.
1996: Andreas Papapetropoulos; G Abou-Mohamed; N Marczin; Ferid Murad; Robert W Caldwell; John D Catravas
Downregulation of nitrovasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1 beta.
British journal of pharmacology 1996;118(6):1359-66.
1996: H Chiao; Robert W Caldwell
The role of substance P in myocardial dysfunction during ischemia and reperfusion.
Naunyn-Schmiedeberg's archives of pharmacology 1996;353(4):400-7.
1996: G Abou-Mohamed; R Nagarajan; T M Ibrahim; Robert W Caldwell
Characterization of the adrenergic activity of arbutamine, a novel agent for pharmacological stress testing.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1996;10(1):39-47.
1996: R Nagarajan; G Abou-Mohamed; T Myers; Robert W Caldwell
A novel catecholamine, arbutamine, for a pharmacological cardiac stress agent.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1996;10(1):31-8.
1995: G Abou-Mohamed; Andreas Papapetropoulos; D Ulrich; John D Catravas; R R Tuttle; Robert W Caldwell
HP-228, a novel synthetic peptide, inhibits the induction of nitric oxide synthase in vivo but not in vitro.
The Journal of pharmacology and experimental therapeutics 1995;275(2):584-91.
1995: H Chiao; SW Pelletier; HK Desai; W R Rebagay; Robert W Caldwell
Effect of diterpenoid alkaloids on cardiac sympathetic efferent and vagal afferent nerve activity.
European journal of pharmacology 1995;283(1-3):103-6.
1995: M S Clarke; Robert W Caldwell; H Chiao; Katsuya Miyake; Paul L McNeil
Contraction-induced cell wounding and release of fibroblast growth factor in heart.
Circulation research 1995;76(6):927-34.
1995: H Chiao; Robert W Caldwell
Local cardiac effects of substance P: roles of acetylcholine and noradrenaline.
British journal of pharmacology 1995;114(2):283-8.
1994: Paul M Heerdt; J D Gallagher; Robert W Caldwell
Effect of halothane on in vivo and in vitro cardiotoxicity of an aminocardenolide.
Journal of cardiovascular pharmacology 1994;23(6):890-6.
1994: G Abou-Mohamed; Robert W Caldwell; G O Carrier; Mohamed Elmazar or El-Mazar; R R Tuttle
Interactions of a novel catecholamine, GP-2-128, with adrenoceptors.
Journal of cardiovascular pharmacology 1994;23(3):492-500.
1994: G Abou-Mohamed; Robert W Caldwell; T M Ibrahim; R R Tuttle
Integrative cardiovascular actions of a novel catecholamine, GP-2-128.
Journal of cardiovascular pharmacology 1994;23(3):485-91.
1992: Robert W Caldwell; W R Rebagay
Effect of transient vagal cold blockade upon reflex actions of a polar and nonpolar cardiac glycoside.
The Journal of pharmacology and experimental therapeutics 1992;262(3):1022-7.
1992: W R Rebagay; Robert W Caldwell
Effects of sinoaortic denervation on the reflex actions of digoxin and a polar aminocardenolide.
Journal of cardiovascular pharmacology 1992;19(1):45-51.
1990: Paul M Heerdt; Robert W Caldwell
The cardiovascular response to digoxin in conscious dogs with left atrial obstruction.
Journal of cardiothoracic anesthesia 1990;4(6):687-94.
1990: W R Rebagay; Robert W Caldwell
Different patterns of autonomic nerve activity produced by a polar vs. a neutral cardiac glycoside.
The Journal of pharmacology and experimental therapeutics 1990;253(1):180-4.
1990: Robert W Caldwell; R Nagarajan; A Chryssanthis; R R Tuttle
Actions of the opioid antagonist, nalmefene, and congeners on reperfusion cardiac arrhythmias and regional left coronary blood flow.
Pharmacology 1990;41(3):161-6.
1989: Emel Songu-Mize; J L Gunter; Robert W Caldwell
Comparative ability of digoxin and an aminosugar cardiac glycoside to bind to and inhibit Na+,K+-adenosine triphosphatase. Effect of potassium.
Biochemical pharmacology 1989;38(21):3689-95.
1989: Paul M Heerdt; Robert W Caldwell
The mechanism of nitrous oxide-induced changes in pulmonary vascular resistance in a dog model of left atrial outflow obstruction.
Journal of cardiothoracic anesthesia 1989;3(5):568-73.
1989: Robert W Caldwell; H S Lowensohn; M A Chryssanthis; C B Nash
Interactions of pyridostigmine with cardiopulmonary systems and their relationships to plasma cholinesterase activity.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1989;12(3):432-41.
1988: Steven L Bealer; Robert W Caldwell; Emel Songu-Mize
Mechanisms of altered sodium excretion after preoptic hypothalamic lesions.
The American journal of physiology 1988;254(1 Pt 2):R84-9.
1987: Emel Songu-Mize; Robert W Caldwell; P G Baer
High and low dietary potassium effects on rat vascular sodium pump activity.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1987;186(3):280-7.
1987: Emel Songu-Mize; Steven L Bealer; Robert W Caldwell
Effect of DOCA-salt treatment duration and anteroventral third ventricle lesions on a plasma-borne sodium pump inhibitor in rats.
Journal of hypertension 1987;5(4):461-7.
1987: Kennerly S Patrick; Robert W Caldwell; R M Ferris; George R Breese
Pharmacology of the enantiomers of threo-methylphenidate.
The Journal of pharmacology and experimental therapeutics 1987;241(1):152-8.
1987: J E Sanderson; Robert W Caldwell; J Hsiao; R Dixon; R R Tuttle
Noninvasive delivery of a novel inotropic catecholamine: iontophoretic versus intravenous infusion in dogs.
Journal of pharmaceutical sciences 1987;76(3):215-8.
1987: Robert W Caldwell; C B Nash; M Smulkowski; R R Tuttle
Cardiovascular effects of KM-13, a new, orally effective, cardiotonic sympathomimetic amine.
Journal of cardiovascular pharmacology 1987;9(3):375-84.
1985: Robert W Caldwell; C B Nash
Effect of an aminocardenolide and digoxin upon atrioventricular refractory period in the dog.
The Journal of pharmacology and experimental therapeutics 1985;235(3):583-8.
1985: T E Mecca; J T Elam; Robert W Caldwell
Mechanism of the pulmonary vasoconstrictor action of digoxin in the dog.
Journal of cardiovascular pharmacology 1985;7(5):833-40.
1984: Robert W Caldwell; Emel Songu-Mize; Steven L Bealer
The vasopressor response to centrally administered ouabain.
Circulation research 1984;55(6):773-9.
1984: Emel Songu-Mize; Steven L Bealer; Robert W Caldwell
Phasic vascular sodium pump changes in deoxycorticosterone-hypertensive rats.
Circulation research 1984;55(3):304-8.
1984: E F Johnson; Robert W Caldwell; H E Berryman; A Miller; K Chetty
Elastic fibers in the anulus fibrosus of the dog intervertebral disc.
Acta anatomica 1984;118(4):238-42.
1983: Robert W Caldwell; J T Elam; T E Mecca; C B Nash
Vascular alpha-adrenergic blocking properties of quinidine.
European journal of pharmacology 1983;94(3-4):185-92.
1983: Emel Songu-Mize; C B Nash; J T Elam; Robert W Caldwell
Metabolism and cardiac actions of a polar aminocardenolide and digoxin in the conscious dog.
The Journal of pharmacology and experimental therapeutics 1983;226(1):65-70.
1983: Robert W Caldwell; C M Blatteis
Effect of chronic hypoxia on angiotensin-induced pulmonary vasoconstriction and converting enzyme activity in the rat.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1983;172(3):346-50.
1983: Emel Songu-Mize; Steven L Bealer; Robert W Caldwell
Effect of anteroventral third ventricle lesions on vascular sodium-pump activity in two-kidney Goldblatt hypertension.
Hypertension 1983;5(2 Pt 2):I89-93.
1982: L S Cook; Robert W Caldwell; C B Nash; J E Doherty; K D Straub
Adrenergic and cholinergic mechanisms in digitalis inotropy.
The Journal of pharmacology and experimental therapeutics 1982;223(3):761-5.
1982: Emel Songu-Mize; Steven L Bealer; Robert W Caldwell
Effect of AV3V lesions on development of DOCA-salt hypertension and vascular Na+-pump activity.
Hypertension 1982;4(5):575-80.
1982: D Cullen; E B Smalley; Robert W Caldwell
New process for T-2 toxin production.
Applied and environmental microbiology 1982;44(2):371-5.
1981: M L Kauker; C B Nash; Robert W Caldwell
Renal tubular transport of a polar cardiac glycoside, ASI-222, in rats; clearance and micropuncture studies.
The Journal of pharmacology and experimental therapeutics 1981;218(3):686-91.
1981: L S Cook; J E Doherty; K D Straub; C B Nash; Robert W Caldwell
Digoxin uptake into peripheral autonomic cardiac nerves: possible mechanism of digitalis-induced antiarrhythmic and toxic electrophysiologic actions.
American heart journal 1981;102(1):58-62.
1981: S K Puryear; C B Nash; Robert W Caldwell
Effect of cardiac beta-adrenergic blockade or denervation on cardiotoxicity of digoxin and an aminosugar cardenolide.
Journal of cardiovascular pharmacology 1981;3(1):113-27.
1980: L S Cook; Robert W Caldwell; C B Nash
Changes in cardiac glycoside activity produced by aminosugar addition.
The Journal of pharmacology and experimental therapeutics 1980;215(1):198-204.
1980: R W Rockhold; Robert W Caldwell
Cardiovascular effects following clonidine microinjection into the nucleus tractus solitarii of the rat.
Neuropharmacology 1980;19(9):919-22.
1980: T E Mecca; J T Elam; C B Nash; Robert W Caldwell
alpha-Adrenergic blocking properties of quinine HCl.
European journal of pharmacology 1980;63(2-3):159-66.
1979: L S Cook; Robert W Caldwell; C B Nash
Structure-activity relationships of an aminosugar cardiac glycoside, ASI-222 HCl, in the heart-lung preparation of the dog.
Journal of cardiovascular pharmacology 1979;1(5):551-9.
1979: R W Rockhold; Robert W Caldwell
Effect of lesions of the nucleus tractus solitarii on the cardiovascular actions of clonidine in conscious rats.
Neuropharmacology 1979;18(4):347-54.
1978: Robert W Caldwell; C B Nash
Comparison of the effects of aminosugar cardiac glycosides with ouabain and digoxin on Na+, K+ -adenosine triphosphatase and cardiac contractile force.
The Journal of pharmacology and experimental therapeutics 1978;204(1):141-8.
1977: L S Cook; Robert W Caldwell; C B Nash
Comparison of the cardiac effects of ASI-222 HCl, an aminosugar cardiac glycoside, and digoxin.
Archives internationales de pharmacodynamie et de thérapie 1977;227(2):220-32.
1977: Robert W Caldwell; C B Nash
Pulmonary and cardiovascular effects of mefloquine methanesulfonate.
Toxicology and applied pharmacology 1977;40(3):437-48.
1976: Robert W Caldwell; C B Nash
Pharmacological studies of a new 4-aminosugar cardiac glycoside (ASI-222).
The Journal of pharmacology and experimental therapeutics 1976;197(1):19-26.
1970: Robert W Caldwell; L I Goldberg
An evaluation of the vasodilation produced by mephentermine and certain other sympathomimetic amines.
The Journal of pharmacology and experimental therapeutics 1970;172(2):297-309.